Letters by company
Generac Holdings INC.
8 letters discussing GNRC. Everything written about it on this site is on its ticker page.
- PenderFund Capital Management Ltd. Pender Global Small/Mid Cap Equity Fund Manager’s Commentary Pender Global Small/Mid Cap Equity Fund maintained a defensive stance amid an AI-related rotation out of semiconductor and high-beta technology shares, citing rising debt-funded hyperscaler capex and concerns over investment returns. The fund initiated Auto Trader, added Copart on weakness, sold Kneat.com after its Thoma Bravo takeout, and defended its Generac thesis while Kinaxis raised guidance. July 2026 AUTO $4.9BGNRC $13BKXS $3.4B
- SouthernSun Asset Management 2Q2026 SMID Cap Investment Commentary SouthernSun SMID Cap Composite took profits in AI-exposed holdings and stayed underweight the data-center buildout, preferring a balanced portfolio amid a narrowly led market. The team argues that Extreme Networks and Generac have durable growth drivers, while Darling Ingredients and Broadridge face temporary or overstated investor concerns. second quarter of 2026 BR $18BDAR $9.7BEXTR $3.2B
- Baird Equity Asset Management Q2 2026 Commentary and Market Outlook Baird Small/Mid Cap Growth added software, AI-infrastructure industrials and commercial-stage therapeutics while exiting holdings where conviction or the original thesis had weakened. The strategy argues that data-center spending supports demand for cooling, power and infrastructure, but maintains discipline as AI-led market leadership becomes increasingly concentrated. Q2 2026 AAON $7.2BAGYS $2.9BALKS $7.2B
- PenderFund Capital Management Ltd. Pender US Small/Mid Cap Equity Fund Manager’s Commentary, July 2026 Amazon’s accelerating AWS demand and long-lived data-centre infrastructure underpin the fund’s view that AI capital spending can earn attractive returns despite near-term volatility. The portfolio emphasizes smaller companies benefiting from power, cooling, compute and grid-investment demand, including Generac, Fluor, Modine and Microchip. JULY 2026 AMZN $2.7T
- Davenport Asset Management The Davenport Funds Quarterly Update Davenport warns that crowded AI infrastructure and semiconductor enthusiasm has displaced value-oriented shares, prompting a more risk-averse stance. Across its funds, the firm trimmed Marvell and UnitedHealth, added Constellation and Berkshire, initiated Stryker, Abbott, IFF and SoFi, and exited impaired Verra Mobility, Caesars and Casey’s. Q2 2026 ABT $173BACN $118BIFF $21B
- Matrix Asset Advisors Capital Markets Commentary and Quarterly Report: 2nd Quarter 2026 Matrix Asset Advisors added Consumer Staples, Healthcare and selected pressured Technology names while trimming holdings that had become oversized or reached target prices. The firm initiated Abbott Laboratories and McDonald’s in its dividend strategy, reduced equity overweighting in balanced accounts, and continued to favor bonds maturing within five years. 2nd Quarter 2026 ABT $173BMCD $164B
- Ariel Investments Portfolio Manager Letter Ariel Fund and Ariel Appreciation Fund maintained scant technology exposure, refusing to chase AI-driven semiconductor and memory-chip rallies because of cyclicality, capital intensity and oversupply risk. They cite Generac and a past Accenture investment as examples of technology-related franchises bought only when quality and valuation met their standards. second quarter of 2026 —
- Andrew Hill Investment Advisors Hurricane Ian Edition of the Client Letter/4Q2022 Andrew Hill Investment Advisors cut equity exposure, added an S&P 500 short position and kept bond maturities short with high credit quality as the Federal Reserve raised rates. The firm favored energy-transition holdings and rebuilding beneficiaries, while waiting for bond yields and earnings expectations to stabilize before extending duration or taking more equity risk. Q3 2022 NEE $162BTSLA $1.5T
